Literature DB >> 20457977

The effective dynamic ranges of standard automated perimetry sizes III and V and motion and matrix perimetry.

Michael Wall1, Kimberly R Woodward, Carrie K Doyle, Gideon Zamba.   

Abstract

OBJECTIVES: To establish the associations between threshold estimates of 4 perimetric tests and to define and compare the tests' effective dynamic ranges.
METHODS: We examined 152 patients with glaucoma and 80 controls using standard automated perimetry (SAP) with stimulus size III, SAP with size V, and motion and matrix perimetry. We explored the intertest associations using principal-components analysis. We defined the effective dynamic range bottom using the frequency of 0-dB trials on retest. We defined the upper effective dynamic range as a value above which fewer than 0.5% of the values fall in the controls. We also calculated the number of discriminable steps from normal to the floor value of the perimeter.
RESULTS: The association between SAP III and V was approximately linear up to a sensitivity of about 20 dB on both tests and with motion and matrix perimetry up to about 25 dB from 0 dB. While the upper bounds were similar among the tests, size V SAP had a lower floor and more discriminable steps.
CONCLUSIONS: The effective dynamic range of SAP III is substantially less than its physically tested limits. Size V stimuli have a greater effective dynamic range than size III by about 1 log unit and have about twice as many discriminable steps.

Entities:  

Mesh:

Year:  2010        PMID: 20457977     DOI: 10.1001/archophthalmol.2010.71

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  27 in total

1.  Localized Changes in Retinal Nerve Fiber Layer Thickness as a Predictor of Localized Functional Change in Glaucoma.

Authors:  Stuart K Gardiner; Brad Fortune; Shaban Demirel
Journal:  Am J Ophthalmol       Date:  2016-08-01       Impact factor: 5.258

Review 2.  Functional assessment of glaucoma: Uncovering progression.

Authors:  Rongrong Hu; Lyne Racette; Kelly S Chen; Chris A Johnson
Journal:  Surv Ophthalmol       Date:  2020-04-26       Impact factor: 6.048

3.  Detecting Change Using Standard Global Perimetric Indices in Glaucoma.

Authors:  Stuart K Gardiner; Shaban Demirel
Journal:  Am J Ophthalmol       Date:  2017-01-25       Impact factor: 5.258

4.  Differences in the Relation Between Perimetric Sensitivity and Variability Between Locations Across the Visual Field.

Authors:  Stuart K Gardiner
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-07-02       Impact factor: 4.799

Review 5.  Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma.

Authors:  C Gustavo De Moraes; Jeffrey M Liebmann; Leonard A Levin
Journal:  Prog Retin Eye Res       Date:  2016-10-20       Impact factor: 21.198

6.  Assessment of the reliability of standard automated perimetry in regions of glaucomatous damage.

Authors:  Stuart K Gardiner; William H Swanson; Deborah Goren; Steven L Mansberger; Shaban Demirel
Journal:  Ophthalmology       Date:  2014-03-12       Impact factor: 12.079

7.  Modeling the relative influence of fixation and sampling errors on retest variability in perimetry.

Authors:  T Maddess
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-30       Impact factor: 3.117

8.  The Effect of Stimulus Size on the Reliable Stimulus Range of Perimetry.

Authors:  Stuart K Gardiner; Shaban Demirel; Deborah Goren; Steven L Mansberger; William H Swanson
Journal:  Transl Vis Sci Technol       Date:  2015-03-27       Impact factor: 3.283

9.  A Method Using Goldmann Stimulus Sizes I to V-Measured Sensitivities to Predict Lead Time Gained to Visual Field Defect Detection in Early Glaucoma.

Authors:  Jack Phu; Sieu K Khuu; Bang V Bui; Michael Kalloniatis
Journal:  Transl Vis Sci Technol       Date:  2018-06-07       Impact factor: 3.283

10.  Pattern Recognition Analysis Reveals Unique Contrast Sensitivity Isocontours Using Static Perimetry Thresholds Across the Visual Field.

Authors:  Jack Phu; Sieu K Khuu; Lisa Nivison-Smith; Barbara Zangerl; Agnes Yiu Jeung Choi; Bryan W Jones; Rebecca L Pfeiffer; Robert E Marc; Michael Kalloniatis
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-09-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.